INVESTMENT PORTFOLIO
IPC INVESTMENTS
Emergence Health (Urgent Care)
Formed by the merger of ClearChoiceMD and CareWell Urgent Care, Emergence Health is a provider of traditional and pediatric urgent care services, as well as in-house ancillary services including x-ray, lab services, pharmacy, and medication assisted treatment.
Industry: Healthcare Services
Sponsor: Iron Path Capital
Pre-IPC Attributed * INVESTMENTS
*These investments (the “Attributed Investments”) are portfolio companies of private investment funds advised by other private equity sponsors (inclusive of their affiliates, the “Prior Firms”), at which one or both of Iron Path’s Managing Partners (i.e., Reistetter and Mraz) previously performed investment activities, are used with the permission of such Prior Firm, and do not constitute “track record” information of Iron Path or any Managing Partner for purposes of the U.S. Investment Advisers Act of 1940, as amended. An investment in any fund sponsored by Iron Path does not represent an interest in any Attributed Investment or any other portfolio company of private investment funds sponsored by the Prior Firms. Such Attributed Investments are presented solely to illustrate the investment strategies which were used by the applicable Managing Partner while at such Prior Firm. No claim is made as to the performance of the Attributed Investments by Iron Path, nor that its Managing Partners (or Iron Path itself) were in any way solely or primarily responsible for acquiring, holding, or exiting such Attributed Investments. Other investment professionals (aside from the Managing Partners) at the Prior Firms participated in the investment process regarding such Attributed Investments, including with respect to sourcing, negotiating, monitoring, and realizing such investments. Final investment decisions concerning the Attributed Investments were made by investment committees of the applicable Prior Firm. No Prior Firm or its affiliates will be involved in investment management decisions regarding Iron Path’s funds and/or portfolio companies.
Comments are closed.